Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms
ConclusionsAlthough anecdotal reports utilizing V-B12 for vasoplegia are available, no higher-level evidence exists. Future work is necessary to further understand the dosing, timing, adverse events, and biochemical mechanisms of V-B12 compared with other therapies such as methylene blue.
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
More News: Anesthesia | Anesthesiology | Biochemistry | Canada Health | Clinical Trials | Databases & Libraries | Liver | Liver Transplant | Poisoning | Science | Transplants | Urology & Nephrology | Vitamin B12 | Vitamins